ALLMedicine™ Mycobacterium Haemophilum Center

Jan 8th, 2021 - Ruxolitinib is a novel oral Janus kinase inhibitor that is used for treatment of myeloproliferative diseases. It exhibits potent anti-inflammatory and immunosuppressive effects, and may increase the risk of opportunistic infections. Here, we repor...

Sep 24th, 2020 - Long non-coding RNAs (lncRNAs) have an established role in cell biology. Among their functions is the regulation of hematopoiesis. They characterize the different stages of hematopoiesis in a more lineage-restricted expression pattern than coding ...

May 20th, 2020 - Infections by opportunistic non-tuberculous mycobacteria (NTM) are rising in global incidence. One emerging, slowly growing NTM is Mycobacterium haemophilum, which can cause skin, lung, bone, and soft tissue infections in immunocompromised patient...

May 9th, 2020 - Non-tuberculous mycobacteria are ubiquitous pathogens causing infections in immunocompromised patients. Here, we describe a kidney transplant recipient who developed skin and soft tissue infection by Mycobacterium haemophilum, complicated by tenos...

Apr 6th, 2020 - Disseminated Cutaneous Infection by Mycobacterium haemophilum in a Woman With Systemic Lupus Erythematosus.|2020|Su T,Jameel AAB,Wang H,Su Z,Lu Y,|

Jan 8th, 2021 - Ruxolitinib is a novel oral Janus kinase inhibitor that is used for treatment of myeloproliferative diseases. It exhibits potent anti-inflammatory and immunosuppressive effects, and may increase the risk of opportunistic infections. Here, we repor...

Sep 24th, 2020 - Long non-coding RNAs (lncRNAs) have an established role in cell biology. Among their functions is the regulation of hematopoiesis. They characterize the different stages of hematopoiesis in a more lineage-restricted expression pattern than coding ...

May 20th, 2020 - Infections by opportunistic non-tuberculous mycobacteria (NTM) are rising in global incidence. One emerging, slowly growing NTM is Mycobacterium haemophilum, which can cause skin, lung, bone, and soft tissue infections in immunocompromised patient...

May 9th, 2020 - Non-tuberculous mycobacteria are ubiquitous pathogens causing infections in immunocompromised patients. Here, we describe a kidney transplant recipient who developed skin and soft tissue infection by Mycobacterium haemophilum, complicated by tenos...

Apr 6th, 2020 - Disseminated Cutaneous Infection by Mycobacterium haemophilum in a Woman With Systemic Lupus Erythematosus.|2020|Su T,Jameel AAB,Wang H,Su Z,Lu Y,|

Oct 3rd, 2019 - Despite negative special stains, an infectious cause was still suspected. Oral doxycycline monohydrate 100 mg twice daily, oral fluconazole 200 mg daily, and econazole cream 1% were prescribed because of concern for mycobacterial infection and ini.

Sep 19th, 2019 - In addition to this change in antibiotic coverage, the patient’s medical oncologist tapered the patient’s immunosuppression considerably. The patient subsequently completed 12 months of therapy with clarithromycin, moxifloxacin, and rifabutin star.

Aug 10th, 2011 - Action Points Explain that Mycobacterium haemophilum was isolated in an immunocompetent patient who developed skin lesions following a tattoo. Note that the lesions had not responded to courses of antibiotics for pyogenic infection but did resolve...